Muh‐Hwa Yang

10.4k total citations · 1 hit paper
164 papers, 7.6k citations indexed

About

Muh‐Hwa Yang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Muh‐Hwa Yang has authored 164 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 64 papers in Molecular Biology and 36 papers in Cancer Research. Recurrent topics in Muh‐Hwa Yang's work include Head and Neck Cancer Studies (30 papers), Cancer Cells and Metastasis (22 papers) and Epigenetics and DNA Methylation (18 papers). Muh‐Hwa Yang is often cited by papers focused on Head and Neck Cancer Studies (30 papers), Cancer Cells and Metastasis (22 papers) and Epigenetics and DNA Methylation (18 papers). Muh‐Hwa Yang collaborates with scholars based in Taiwan, United States and China. Muh‐Hwa Yang's co-authors include Kou-Juey Wu, Shyh‐Kuan Tai, Chi-Hung Huang, Shyue‐Yih Chang, Hsin-Yi Lan, Cheng‐Hwai Tzeng, Oscar K. Lee, Shou‐Yen Kao, Wenhao Yang and Po‐Min Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Muh‐Hwa Yang

157 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

2010 543 citations Muh‐Hwa Yang, Dennis Shin-Shian Hsu et al. profile →

Peers

Countries citing papers authored by Muh‐Hwa Yang

Since Specialization

Citations

This map shows the geographic impact of Muh‐Hwa Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muh‐Hwa Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muh‐Hwa Yang more than expected).

Fields of papers citing papers by Muh‐Hwa Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muh‐Hwa Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muh‐Hwa Yang. The network helps show where Muh‐Hwa Yang may publish in the future.

Co-authorship network of co-authors of Muh‐Hwa Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Muh‐Hwa Yang. A scholar is included among the top collaborators of Muh‐Hwa Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muh‐Hwa Yang. Muh‐Hwa Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study 2025 ·Clinical Cancer Research ·Lin‐Quan Tang, Sai-Lan Liu, Muh‐Hwa Yang, Hui‐Ching Wang, Yujuan Zhou, Kunyu Yang, Qun Li, Mun N. Hui, (unknown), (unknown), Li‐Tzong Chen, (unknown), (unknown), (unknown), Shuang Wang, (unknown), Hanjie Shen, Yu Wang, Ye Guo, Hai‐Qiang Mai	0
2	Ribonuclease 1 Induces T‐Cell Dysfunction and Impairs CD8⁺ T‐Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1 2025 ·Advanced Science ·Wenhao Yang, (unknown), (unknown), Peng Ye, (unknown), Hao‐Ching Wang, (unknown), Heng‐Hsiung Wu, Hung‐Rong Yen, Shao‐Chun Wang, Jong‐Ho Cha, Xiuwen Yan, Muh‐Hwa Yang, Mien‐Chie Hung	1
3	Hypoxia-Induced Long Noncoding RNA HIF1A- AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer 2024 ·Cancer Immunology Research ·Tsai‐Tsen Liao, (unknown), (unknown), (unknown), (unknown), (unknown), Shyh‐Kuan Tai, Pen‐Yuan Chu, Jing-Wen Shih, Hsing‐Jien Kung, Muh‐Hwa Yang	14
4	Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas 2024 ·Alimentary Pharmacology & Therapeutics ·Yi‐Ping Hung, Pei‐Chang Lee, Yen‐Hwa Chang, Muh‐Hwa Yang, Chao‐Hua Chiu, Ming‐Huang Chen, Keng‐Hsin Lan, I‐Cheng Lee, Ming‐Chih Hou, Yee Chao, Yi‐Hsiang Huang	3
5	GMI, a fungal immunomodulatory protein, ameliorates SARS-CoV-2 envelope protein-induced inflammation in macrophages via inhibition of MAPK pathway 2023 ·International Journal of Biological Macromolecules ·(unknown), Hsin Yeh, (unknown), (unknown), (unknown), Li‐Kai Wang, Ting‐Ting Chang, Muh‐Hwa Yang, Tung‐Yi Lin	8
6	Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab 2022 ·Cancers ·(unknown), Chi‐Tsun Chiu, Chih‐Liang Wang, Tsung‐Ying Yang, Chien‐Ying Liu, Chih‐Teng Yu, (unknown), Chih‐Hsi S. Kuo, Chin‐Chou Wang, Muh‐Hwa Yang, Cheng‐Ta Yang	9
7	Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma 2022 ·Neoplasia ·(unknown), (unknown), Ying‐Ju Kuo, Hsin‐Yi Lan, Muh‐Hwa Yang, Pen‐Yuan Chu	10
8	Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer 2021 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), (unknown), Pang‐Hung Hsu, Yung‐Ming Jeng, Yi-Fang Tsai, Muh‐Hwa Yang, Wendy W. Hwang‐Verslues	47
9	Oncologic results and quality of life in patients with T3 glottic cancer after transoral laser microsurgery 2021 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), Ling-Wei Wang, Muh‐Hwa Yang, Pen‐Yuan Chu	9
10	LncRNA CCAL Promotes Angiogenesis Through Regulating the MiR-29b/ANGPTL4 Axis in Osteosarcoma 2020 ·SHILAP Revista de lepidopterología ·Shiyi Chen, Muh‐Hwa Yang, (unknown)	1
11	DDX3 Activates CBC-eIF3–Mediated Translation of uORF-Containing Oncogenic mRNAs to Promote Metastasis in HNSCC 2018 ·Cancer Research ·(unknown), (unknown), Muh‐Hwa Yang, Woan‐Yuh Tarn	68
12	Lymphotoxin-β Interacts with Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer 2017 ·Clinical Cancer Research ·Dennis Shin-Shian Hsu, Wei‐Lun Hwang, Chiou‐Hwa Yuh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wen‐Hao Hsu, Hsin-Yi Lan, Hsiao-Jung Wang, Shyh‐Kuan Tai, Mien‐Chie Hung, Muh‐Hwa Yang	24
13	Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan 2015 ·Medicine ·Chung‐Jen Teng, Leh‐Kiong Huon, Yu‐Wen Hu, Chiu‐Mei Yeh, Yee Chao, Muh‐Hwa Yang, Tzeng‐Ji Chen, Yi‐Ping Hung, Chia‐Jen Liu	26
14	Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer Cells 2013 ·Cancer Research ·Cheng‐Chi Chang, Wen‐Hao Hsu, (unknown), (unknown), Mark Yen‐Ping Kuo, Been‐Ren Lin, Szu‐Ta Chen, Shyh‐Kuan Tai, Min‐Liang Kuo, Muh‐Hwa Yang	75
15	Serum Albumin is an Important Prognostic Factor for Carotid Blowout Syndrome 2013 ·Japanese Journal of Clinical Oncology ·Hsueh‐Ju Lu, Kuo-Wei Chen, Ming‐Huang Chen, Pen‐Yuan Chu, Shyh‐Kuan Tai, Cheng‐Hwai Tzeng, Peter Mu‐Hsin Chang, Muh‐Hwa Yang	6
16	Chromosome Instability Modulated by BMI1–AURKA Signaling Drives Progression in Head and Neck Cancer 2012 ·Cancer Research ·(unknown), (unknown), (unknown), Shyh‐Kuan Tai, Dennis Shin-Shian Hsu, Yawei Chen, Yann-Jang Chen, Cheng‐Chi Chang, Cheng‐Hwai Tzeng, Muh‐Hwa Yang	66
17	Epithelial–Mesenchymal Transition Induced by TNF-α Requires NF-κB–Mediated Transcriptional Upregulation of Twist1 2012 ·Cancer Research ·Chia‐Wei Li, Weiya Xia, Longfei Huo, Seung-Oe Lim, Yun Wu, Jennifer L. Hsu, Chi-Hong Chao, Hirohito Yamaguchi, (unknown), Qingqing Ding, Yan Wang, Yun‐Ju Lai, Adam M. LaBaff, (unknown), Been‐Ren Lin, Muh‐Hwa Yang, Gabriel N. Hortobágyi, Mien‐Chie Hung	389
18	Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer 2010 ·Clinical Cancer Research ·Dennis Shin-Shian Hsu, Hsin-Yi Lan, Chi-Hung Huang, Shyh‐Kuan Tai, Shyue‐Yih Chang, (unknown), Cheng‐Chi Chang, Cheng‐Hwai Tzeng, Kou-Juey Wu, Jung‐Yie Kao, Muh‐Hwa Yang	131
19	Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia 2008 ·International Journal of Oncology ·Po‐Min Chen, Chueh‐Chuan Yen, Weishu Wang, (unknown), (unknown), Tzeon‐Jye Chiou, Liu H, Muh‐Hwa Yang	12
20	Extended Lamivudine Therapy against Hepatitis B Virus Infection in Hematopoietic Stem Cell Transplant Recipients 2006 ·Biology of Blood and Marrow Transplantation ·Liang-Tsai Hsiao, Tzeon-Jye Chiou, Liu H, (unknown), Yu‐Chen Lin, Ta‐Chung Chao, Wei-Shu Wang, Chueh‐Chuan Yen, Muh‐Hwa Yang, Cheng‐Hwai Tzeng, Po‐Min Chen	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact